Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lung Neoplasms × Curcumin × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 3 Colonic Neoplasms 3 Neoplasms 2 Uterine Cervical Dysplasia 1 Stomatitis 1 Rectal Neoplasms 1 Pain 1 Neurofibromatosis 1 1 Lung Neoplasms 1 Castration Sensitive Prostate Cancer 1 Advanced Cancers 1

Interventions

Radiotherapy 31 pembrolizumab 30 Cisplatin 29 Carboplatin 28 Pemetrexed 20 Paclitaxel 19 Docetaxel 16 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 Gemcitabine 15 Nivolumab 14 Cyclophosphamide 14 osimertinib 13 Irinotecan 12 Etoposide 12 Bevacizumab 12 durvalumab 11 Erlotinib Hydrochloride 10 Radiation 9 Cetuximab 9 Topotecan 8 Immunoglobulin G 8 Disulfides 8 Celecoxib 8 fludarabine 7 Radiosurgery 7 Fluorouracil 7 atezolizumab 6 Everolimus 6 Biopsy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02321293 2015-09-02

CURCUMIN

Lady Davis Institute

Phase 1 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡